NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 239 filers reported holding NEKTAR THERAPEUTICS in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $414,000 | -62.0% | 29,577 | -51.3% | 0.00% | -66.7% |
| Q3 2021 | $1,090,000 | +4.7% | 60,759 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $1,041,000 | +231.5% | 60,759 | +252.3% | 0.01% | +100.0% |
| Q3 2019 | $314,000 | -72.3% | 17,247 | -45.8% | 0.00% | -70.0% |
| Q2 2019 | $1,134,000 | +19.1% | 31,847 | +12.5% | 0.01% | +11.1% |
| Q1 2019 | $952,000 | -10.4% | 28,297 | -12.5% | 0.01% | -10.0% |
| Q4 2018 | $1,063,000 | -20.1% | 32,343 | +48.2% | 0.01% | 0.0% |
| Q3 2018 | $1,330,000 | +13.3% | 21,820 | -9.2% | 0.01% | 0.0% |
| Q2 2018 | $1,174,000 | -23.8% | 24,020 | +65.7% | 0.01% | -33.3% |
| Q1 2018 | $1,541,000 | – | 14,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIRSCHWELL & LOEWY INC | 588,908 | $7,138,000 | 1.23% |
| Granahan Investment Management | 3,693,956 | $44,771,000 | 1.21% |
| NEA Management Company, LLC | 1,825,600 | $22,126,000 | 1.09% |
| FIC CAPITAL INC | 150,868 | $1,829,000 | 0.75% |
| Rhenman & Partners Asset Management AB | 181,797 | $2,203,000 | 0.66% |
| SOPHROSYNE CAPITAL LLC | 60,200 | $728,000 | 0.64% |
| HARVEY CAPITAL MANAGEMENT INC | 130,400 | $1,580,000 | 0.63% |
| Artal Group S.A. | 1,300,000 | $15,756,000 | 0.57% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 564,418 | $6,840,000 | 0.47% |
| OppenheimerFunds, Inc. | 24,400,000 | $295,728,000 | 0.35% |